Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) — Defensive Interval Ratio

Latest as of September 2025: 305 days

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) has a Defensive Interval Ratio of 305 days as of September 2025. Defensive assets of $566.27K (cash $-, short-term investments $-, receivables $566.27K) cover 305 days of daily cash needs of $1.86K/day. Check tangible equity quality of Drugs Made In America Acquisition II Cor to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

305 days
Days of operational coverage

Defensive Assets

$566.27K
Cash + ST Investments + Receivables

Daily Cash Need

$1.86K
Current Liabilities ÷ 365

Current Liabilities

$677.35K
USD

Annual Defensive Interval Ratio for Drugs Made In America Acquisition II Corp. Ordinary Shares (None–None)

The table below presents the year-by-year Defensive Interval Ratio for Drugs Made In America Acquisition II Corp. Ordinary Shares from None to None, covering 0 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Drugs Made In America Acquisition II Cor market cap and net worth.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)